OBJECTIVE -Glycemic control (HbA 1c [A1C]) is strongly associated with microvascular disease in individuals with diabetes, but its relation to macrovascular disease and atherosclerosis is less clear. This study examines the relationship between A1C, carotid intima-media thickness (IMT), and traditional cardiovascular risk factors in individuals with diabetes.
RESEARCH DESIGN AND METHODS-A cross-sectional study of 2,060 people with diagnosed and undiagnosed (unrecognized) diabetes in the Atherosclerosis Risk in Communities study was performed.RESULTS -LDL and HDL cholesterol, plasma triglycerides, and waist-to-hip ratio were significantly associated with A1C after multivariable adjustment. African Americans with undiagnosed and diagnosed diabetes had significantly elevated A1C values compared with whites, even after adjustment for potentially confounding factors. There was a graded association between A1C and carotid IMT. In a fully adjusted model in individuals with undiagnosed diabetes, the odds ratio (OR) of being in the highest quartile of IMT versus the lowest was 2.46 (95% CI 1.16 -5.03, comparing the highest quartile of A1C to the lowest). In people with diagnosed diabetes, the comparable OR was 2.62 (1.36 -5.06).CONCLUSIONS -This study identified several important associations between A1C and known risk factors for cardiovascular disease and suggested that A1C is independently related to carotid IMT. Chronically elevated glucose levels may contribute to the development of atherosclerosis in people with diabetes, independent of other risk factors.
Diabetes Care 28:1965-1973, 2005R ecent estimates suggest that there are ϳ18 million individuals with diabetes in the U.S., affecting ϳ9% of the total adult population (1). Glycemic control is a focus of clinical treatment of diabetes. HbA 1c (A1C), a measure of long-term glycemic control, is used to monitor and guide clinical treatment in individuals with diabetes. Elevated A1C levels are strongly associated with diabetes-related microvascular disease (2-4), but whether A1C is independently associated with the progression of atherosclerosis (5) and cardiovascular events (6) in individuals with diabetes remains controversial.The U.K. Prospective Diabetes Study (UKPDS) showed an overall 25% reduction (P ϭ 0.0099) in the risk of microvascular disease end points in the intensively treated group (median A1C ϭ 7.0%) compared with the conventionally treated group (7.9%) after 10 years of follow-up (2). There is some evidence from epidemiologic studies that similar reductions in A1C may also reduce the risk of cardiovascular disease in people with diabetes (6,7). In the UKPDS trial, there was a 16% reduction (P ϭ 0.052) in myocardial infarction observed for the intensively treated group compared with the conventionally treated group. Although the findings were only of borderline statistical significance, the UKPDS provided intriguing evidence of glycemic control as a possible modifiable risk factor for coronary heart disease.Few studies have explicitly examined the asso...